| __timestamp | Incyte Corporation | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 347523000 | 581800000 |
| Thursday, January 1, 2015 | 479514000 | 671900000 |
| Friday, January 1, 2016 | 581861000 | 876700000 |
| Sunday, January 1, 2017 | 1326361000 | 857900000 |
| Monday, January 1, 2018 | 1197957000 | 822200000 |
| Tuesday, January 1, 2019 | 1154111000 | 778200000 |
| Wednesday, January 1, 2020 | 2215942000 | 512600000 |
| Friday, January 1, 2021 | 1458179000 | 681000000 |
| Saturday, January 1, 2022 | 1585936000 | 662200000 |
| Sunday, January 1, 2023 | 1627594000 | 910700000 |
| Monday, January 1, 2024 | 2606848000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and Viatris Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Incyte Corporation's R&D expenses surged by over 360%, peaking in 2020. This upward trajectory underscores Incyte's aggressive pursuit of groundbreaking therapies, reflecting a robust commitment to innovation.
Viatris Inc., on the other hand, maintained a more stable R&D expenditure, with a modest increase of around 56% over the same period. This steady approach highlights Viatris's focus on optimizing existing products while cautiously exploring new opportunities.
As these companies navigate the future, their R&D strategies will continue to shape their competitive edge in the pharmaceutical industry.
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Incyte Corporation or Vericel Corporation: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?